Y43.0
Antiallergic and antiemetic drugs
⇄ Primary-code rule changed vs QĐ4469
Coding rules (TT06)
- ●Cannot be used as primary diagnosis
Coding guidance (WHO 2019)
Excl.: phenothiazine-based neuroleptics (Y49.3)
Sibling codes
Y43Primarily systemic agentsY43.1Antineoplastic antimetabolitesY43.2Antineoplastic natural productsY43.3Other antineoplastic drugsY43.4Immunosuppressive agentsY43.5Acidifying and alkalizing agentsY43.6Enzymes, not elsewhere classifiedY43.8Other primarily systemic agents, not elsewhere classifiedY43.9Primarily systemic agent, unspecified